Ashmi Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-07-2024
- Paid Up Capital ₹ 0.68 M
as on 17-07-2024
- Company Age 28 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.95 Cr
as on 17-07-2024
- Satisfied Charges ₹ 2.65 Cr
as on 17-07-2024
- Revenue %
(FY 2023)
- Profit -59.77%
(FY 2023)
- Ebitda -394.42%
(FY 2023)
- Net Worth -0.69%
(FY 2023)
- Total Assets 58.27%
(FY 2023)
About Ashmi Life Science
The Corporate was formerly known as Ashmi Pharma-Chem Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.68 M.
The company currently has active open charges totaling ₹4.95 Cr. The company has closed loans amounting to ₹2.65 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashvinkumar Patel and Mayur Patel serve as directors at the Company.
- CIN/LLPIN
U24231GJ1996PTC030262
- Company No.
030262
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jul 1996
- Date of AGM
01 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ashmi Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashvinkumar Patel  | Director | 28-Apr-2008 | Current |
| Mayur Patel | Director | 28-Apr-2008 | Current |
Financial Performance of Ashmi Life Science.
Ashmi Life Science Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 59.77% decrease in profit. The company's net worth dipped by a decrease of 0.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ashmi Life Science?
In 2023, Ashmi Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
R B Metasteel Private LimitedActive 13 years 5 monthsAshvinkumar Patel and Mayur Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 21 Jul 2023 | ₹4.95 Cr | Open |
State Bank Of India Creation Date: 22 Nov 2014 | ₹2.65 Cr | Satisfied |
How Many Employees Work at Ashmi Life Science?
Unlock and access historical data on people associated with Ashmi Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ashmi Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ashmi Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
